C Type Natriuretic Peptide
Mostrando 1-12 de 46 artigos, teses e dissertações.
-
1. Mitigating effect of tanshinone IIA on ventricular remodeling in rats with pressure overload-induced heart failure
Abstract Purpose To investigate the effect of tanshinone IIA (TIIA) on ventricular remodeling in rats with pressure overload-induced heart failure. Methods Pressure overload-induced heart failure model (abdominal aortic coarctation) was established in 40 rats, which were divided into model and 5, 10 and 20 mg/kg TIIA groups. Ten rats receiving laparotomy e
Acta Cir. Bras.. Publicado em: 14/10/2019
-
2. Collaborative care model improves self-care ability, quality of life and cardiac function of patients with chronic heart failure
Chronic heart failure (CHF) is a common chronic disease that requires much care. This study aimed to explore the effects of collaborative care model (CCM) on patients with CHF. A total of 114 CHF patients were enrolled in this study, and were randomly and equally divided into two groups: control and experimental. Patients in the two groups received either us
Braz J Med Biol Res. Publicado em: 21/09/2017
-
3. Hormone therapy with tamoxifen reduces plasma levels of NT-B-type natriuretic peptide but does not change ventricular ejection fraction after chemotherapy in women with breast cancer
The objective of this study was to evaluate the effect of tamoxifen on the plasma concentration of NT-pro-B-type natriuretic peptide (NT-proBNP) in women undergoing chemotherapy for breast cancer and to correlate changes in NT-proBNP with the left ventricular ejection fraction (LVEF). Over a period of 12 months, we followed 60 women with a diagnosis of breas
Braz J Med Biol Res. Publicado em: 21/11/2014
-
4. Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
OBJECTIVES:This study aimed to investigate the clinical correlation between angiographic coronary atherosclerosis and N-terminal pro-B-type natriuretic peptide along with other known correlated factors.METHODS:In total, 153 patients with a diagnostic hypothesis of stable angina, unstable angina or acute myocardial infarction were classified as group A (patie
Clinics. Publicado em: 2014-06
-
5. Short-term add-on therapy with angiotensin receptor blocker for end-stage inotrope-dependent heart failure patients: B-type natriuretic peptide reduction in a randomized clinical trial
OBJECTIVE: We aimed to evaluate angiotensin receptor blocker add-on therapy in patients with low cardiac output during decompensated heart failure. METHODS: We selected patients with decompensated heart failure, low cardiac output, dobutamine dependence, and an ejection fraction <0.45 who were receiving an angiotensin-converting enzyme inhibitor. The pati
Clinics. Publicado em: 2014
-
6. Efeitos vasculares induzidos pelo peptídeo natriurético tipo C (CNP) em aorta de ratos normotensos e hipertensos renais / Vascular effects induced by C-type natriuretic peptide (CNP) on aorta from normotensive and renovascular hypertensive rats.
O peptídeo natriurético tipo C (CNP) é descrito como agonista vasodilatador do músculo liso vascular de artérias e veias, podendo ser produzido e liberado do endotélio vascular frente a diversos estímulos. Este promove o relaxamento vascular através da interação com seu receptor associado à enzima guanilil ciclase particulada (GCp) de membrana, le
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 04/07/2011
-
7. Predictors of low cardiac output in decompensated severe heart failure
OBJECTIVE: To identify predictors of low cardiac output and mortality in decompensated heart failure. INTRODUCTION: Introduction: Patients with decompensated heart failure have a high mortality rate, especially those patients with low cardiac output. However, this clinical presentation is uncommon, and its management is controversial. METHODS: We studied a c
Clinics. Publicado em: 2011
-
8. Analysis of the Amino-terminal Pro-B-Type Natriuretic Peptide and Risk Factors for Angiographic Atherosclerotic Coronary Occlusion in Patients with the Diagnostic Hy-pothesis of Ischemic Heart Disease. / AnÃlise do fragmento amino-terminal do pro-peptÃdeo natriurÃtico tipo b e de fatores de risco para oclusÃo coronariana aterosclerÃtica angiogrÃfica em pacientes com a hipÃtese diagnÃstica de cardiopatia isquÃmica
As doenÃas cardiovasculares, incluindo a cardiopatia isquÃmica aterosclerÃtica, sÃo a princi-pal causa de morte no Brasil. A aterosclerose à doenÃa inflamatÃria crÃnica que se inicia na infÃncia, progride lentamente e se expressa dÃcadas depois. Ela principia por disfunÃÃo do endotÃlio, tem patogÃnese multifatorial e tem, como principais fatore
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 20/11/2009
-
9. Quantificação do mRNA BNP Miocárdico em Ratas Submetidas à Isquemia/Reperfusão na Ausência de Distensão Ventricular. / Quantification of myocardial BNP mRNA in rats submi tted to ischemia/reperfusionin in the absence of ventricular distension.
Objetivo. Existem evidências de que o aumento do teor do mRNA BNP miocárdico ou do BNP plasmático está associado à isquemia miocárdica, porém a relação entre isquemia aguda seguida de reperfusão e o comportamento do mRNA BNP miocárdico não está ainda bem esclarecida. O objetivo desse estudo foi determinar se existe relação entre isquemia/reper
Publicado em: 2009
-
10. Avaliação dos efeitos cardiovasculares do imatinibe em pacientes com leucemia mielóide crônica.
Background: Imatinib mesylate (IM), a tyrosine kinase inhibitor that targets BCR-ABL, PDGFRA and c-kit, has become the first line of therapy for patients with chronic myeloid leukemia (CML) and advanced gastrointestinal stromal tumors (GIST). A recent publication suggests that IM might have myocardial toxicity. It reported ten individuals who developed sever
Publicado em: 2008
-
11. Efeitos da aprotinina em crianças com cardiopatia congênita acianogênica operadas com circulação extracorpórea / Effects of aprotinin in children with acianogenic congenital heart disease submitted to correction with extracorporeal circulation
Introduction. Aprotinin seems to reduce the need for transfusion, the inflammatory process and myocardial damage after extracorporeal circulation (ECC). Material and Methods. A prospective randomized study was conducted on children aged 30 days to 4 years submitted to correction of acyanogenic congenital heart disease with ECC and divided into two groups: Co
Publicado em: 2006
-
12. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide
Longitudinal bone growth is determined by the process of endochondral ossification in the cartilaginous growth plate, which is located at both ends of vertebrae and long bones and involves many systemic hormones and local regulators. Natriuretic peptides organize a family of three structurally related peptides: atrial natriuretic peptide, brain natriuretic p
The National Academy of Sciences.